Great news for ADHD treatment! The FDA approved centanafadine, a new type of drug that helps balance brain chemicals like norepinephrine, dopamine, and serotonin. Phase 3 trials showed symptom reduction in just 1 week. More options mean hope for many.
FDA Approves First-in-Class Centanafadine for ADHD in Adults and Pediatric PatientsThe FDA has approved once-daily centanafadine (Sintriyo), a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor, for the treatment of attention-deficit hyperactivity disorder (ADwww.otsuka-us.com